mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.8 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |